Regadenoson 67457-0994
Product NDC
67457-0994- Manufacturer
- Mylan Institutional Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 21, 2023
- Application
- ANDA213856
Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Regadenoson | .4 mg/5mL |
Drug Class
Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]
Packaging Options(1)
1 SYRINGE in 1 CARTON (67457-994-05) / 5 mL in 1 SYRINGE